PR, R., C, F., J, M., & F, C. (2024). Antiandrogen Withdrawal Syndrome After Discontinuation of Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer: A Report of Two Clinical Cases and a Literature Review. Cureus, 16(6), e63506. https://doi.org/10.7759/cureus.63506
Chicago Style (17th ed.) CitationPR, Rodrigues, Faustino C, Maurício J, and Carneiro F. "Antiandrogen Withdrawal Syndrome After Discontinuation of Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer: A Report of Two Clinical Cases and a Literature Review." Cureus 16, no. 6 (2024): e63506. https://doi.org/10.7759/cureus.63506.
MLA (9th ed.) CitationPR, Rodrigues, et al. "Antiandrogen Withdrawal Syndrome After Discontinuation of Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer: A Report of Two Clinical Cases and a Literature Review." Cureus, vol. 16, no. 6, 2024, p. e63506, https://doi.org/10.7759/cureus.63506.